Vivani director granted options for 36,000 shares

Vivani Medical director August J. Moretti received a grant of non-qualified stock options covering 36,000 shares of common stock at an exercise price of $1.22 per share.

Rhea-AI Filing Summary

Vivani Medical director August J. Moretti received a grant of non-qualified stock options covering 36,000 shares of common stock at an exercise price of $1.22 per share. The award was made under Vivani’s Non-Employee Director Compensation Policy and vests in monthly installments over three years, with the options expiring on June 23, 2036. This is a compensation-related equity grant rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 36,000 shares

Grant/Award 1 txn

Insider Moretti August J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	36,000	$1.22	$44K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 36,000 contracts (Direct)

Footnotes (2)

1. F1. Initial grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
2. F2. The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date.

Key Figures

Option grant size: 36,000 shares Exercise price: $1.22 per share Underlying shares: 36,000 shares +3 more

6 metrics

Option grant size 36,000 shares Non-qualified stock option award to director

Exercise price $1.22 per share Strike price of non-qualified stock option

Underlying shares 36,000 shares Underlying Vivani common stock for the option

Post-grant derivative holdings 36,000 options Total derivative shares following this grant

Option expiration date June 23, 2036 Expiration of non-qualified stock option

Vesting schedule Monthly over 3 years From grant date, subject to continued service

Key Terms

Non-Qualified Stock Option, Non-Employee Director Compensation Policy, exercise price, vests in monthly installments

4 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

Non-Employee Director Compensation Policy financial

"Initial grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy."

exercise price financial

"conversion_or_exercise_price": "1.2200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests in monthly installments financial

"The option vests in monthly installments over the three-year period following the grant date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vivani Medical (VANI) director August J. Moretti report on this Form 4?

August J. Moretti reported receiving a grant of non-qualified stock options for 36,000 Vivani Medical common shares. The options were awarded under the company’s Non-Employee Director Compensation Policy as part of director compensation rather than through an open-market transaction.

How many Vivani Medical (VANI) shares are covered by Moretti’s new stock options?

The grant covers options on 36,000 shares of Vivani Medical common stock. These options give him the right to buy that number of shares, subject to vesting over time and compliance with the grant’s terms and conditions.

What is the exercise price of August Moretti’s Vivani Medical (VANI) stock option grant?

The options have an exercise, or strike, price of $1.22 per share. This is the price at which he can purchase Vivani Medical common stock when the options are vested and exercised within the specified term.

How do August Moretti’s Vivani Medical (VANI) options vest over time?

The options vest in monthly installments over three years following the grant date. Vesting is conditioned on his continued service as a non-employee director through each applicable vesting date during that three-year period.

When do August Moretti’s Vivani Medical (VANI) stock options expire?

The options expire on June 23, 2036, giving a multi-year exercise window. After this expiration date, any unexercised options will lapse and no longer give the right to purchase Vivani Medical common shares.

Is August Moretti’s Vivani Medical (VANI) Form 4 transaction a market buy or sell?

The filing reflects a grant or award of stock options, not a market buy or sell. It is an equity compensation grant under Vivani’s Non-Employee Director Compensation Policy rather than an open-market share purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 02:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moretti August J

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.22	06/24/2026		A		36,000		(1)(2)	06/23/2036	Common Stock	36,000(2)	$1.22(2)	36,000(2)	D

Explanation of Responses:

1. Initial grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.

2. The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date.

	/s/ Anthony Baldor, Attorney-in-fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)